259 related articles for article (PubMed ID: 9366158)
1. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
Yamazaki Y; Matsumoto H; Takeda A; Takahashi T; Sasaki N; Takahashi M; Tsuji T; Fujikane T; Shimizu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
[TBL] [Abstract][Full Text] [Related]
2. [Effects of denopamine on hemodynamics and blood gases in secondary pulmonary hypertension].
Ido A; Tsuji T; Shimizu T; Fukuzawa J; Fujiuchi S; Fujita Y; Ohki Y; Sasaki N; Sakai E; Onodera S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1553-9. PubMed ID: 1808377
[TBL] [Abstract][Full Text] [Related]
3. [Effects of low dose pimobendan in patients with cor-pulmonale].
Nakatani M; Shirotani T; Kobayashi K; Satomi S; Ikeda Y; Kuniyoshi T; Tajiri E; Furuta Y; Motooka T
J Cardiol; 1999 Aug; 34(2):79-83. PubMed ID: 10466089
[TBL] [Abstract][Full Text] [Related]
4. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
Tsuda T; Izumi T; Kodama M; Hanawa H; Ohshima M; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Shibata A
J Cardiol; 1992; 22(4):721-9. PubMed ID: 1343639
[TBL] [Abstract][Full Text] [Related]
5. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
Cheng D; Chen W; Jiang J
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
[TBL] [Abstract][Full Text] [Related]
6. [Effect of oxygen inhalation on hemodynamics in chronic thromboembolic pulmonary hypertension].
Pitton MB; Düber C; Mayer E; Thelen M
Rofo; 1998 Jan; 168(1):64-7. PubMed ID: 9501936
[TBL] [Abstract][Full Text] [Related]
7. [The effects of oxygen and vasodilators on pulmonary hemodynamics and blood gases in chronic lung disease].
Hirasima T; Matsumoto T; Hirata N; Kimura T; Fukuda K; Takenaka S; Shima K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1655-61. PubMed ID: 1447840
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
11. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
13. [Effects of diprophylline on pulmonary hypertension in patients with chronic pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun; 15(3):153-4, 190. PubMed ID: 1473187
[TBL] [Abstract][Full Text] [Related]
14. Oral tadalafil in pulmonary artery hypertension: a prospective study.
Aggarwal P; Patial RK; Negi PC; Marwaha R
Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
16. Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
Böger RH; Mügge A; Bode-Böger SM; Heinzel D; Höper MM; Frölich JC
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):323-8. PubMed ID: 8864793
[TBL] [Abstract][Full Text] [Related]
17. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
19. Vasodilatory treatment of pulmonary hypertension.
Widimský J
Eur J Respir Dis; 1986 Mar; 68(3):161-6. PubMed ID: 2870937
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
